ArticleThe oncologist2021

Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Hani Babiker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.